In addition, according to Germany and Netherlands, a co-formulant (Antifoam B) containing octamethylcyclotetrasiloxane (CAS 556-67-2) is present in the product. As octamethylcyclotetrasiloxane is included by the Agency in the candidate list of substances of very high concern for authorisation [Candidate List of substances of very high concern for Authorisation - ECHA (europa.eu)], pursuant to Article 59 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council [Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1, ELI: http://data.europa.eu/eli/reg/2006/1907/oj).], as it is a persistent, bioaccumulative and toxic (PBT) and a very persistent and very bioaccumulative (vPvB) substance according to the criteria set out in Annex XIII to Regulation (EC) No 1907/2006, Germany and Netherlands consider that Antifoam B meets the definition of a substance of concern laid down in Article 3(1), point (f), of Regulation (EU) No 528/2012 and that therefore a risk assessment should be performed in accordance with point 14 of Annex VI to Regulation (EU) No 528/2012.
Recital 4, Decision_act (EU) 2024/1305
In forcesince 8 May 2024
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 Decembe…59Law
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…3Law
- celex=31976L0769
- celex=31991L0155
- celex=31993L0067
- celex=31993L0105
- celex=31993R0793
- celex=31994R1488
- celex=31999L0045
- celex=32000L0021
- num:eu=1976/769
- num:eu=1991/155